Page 2 - Small Cap Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Apr 29, 2024

Discover small cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2161

JBM (Healthcare)
HK$0.87-3.3%-19.4%HK$720.4mn/aPE7.4xn/a7.9%

2126

JW (Cayman) Therapeutics
HK$1.792.3%-45.1%HK$722.3mHK$2.72PS3.8xE28.3%n/a

6628

Transcenta Holding
HK$1.817.1%-54.6%HK$735.9mHK$8.21PS12.6xE-2.4%n/a

503

Lansen Pharmaceutical Holdings
HK$1.790%23.6%HK$750.6mn/aPE13xn/a2.7%

6622

Zhaoke Ophthalmology
HK$1.57-1.3%-57.9%HK$857.4mHK$7.69PS42.3xS85.8%n/a

2142

HBM Holdings
HK$1.182.6%-38.9%HK$864.6mn/aPE4.8xn/an/a

2137

Brii Biosciences
HK$1.2527.6%-67.6%HK$912.0mHK$4.66PS15.1xE15.9%n/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.64-10.9%-2.4%HK$918.8mn/aPE5.7xn/a32.9%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.15-5.7%0.9%HK$993.1mn/aPE5.6xn/a5.2%

2616

CStone Pharmaceuticals
HK$0.882.3%-72.6%HK$1.1bHK$3.45PS2.2xE56.9%n/a

1873

Viva Biotech Holdings
HK$0.5321.8%-62.9%HK$1.1bn/aPB0.3xn/an/a

2633

Jacobson Pharma
HK$0.570%-38.0%HK$1.1bn/aPE4.7xn/a8.6%

1061

Essex Bio-Technology
HK$2.302.2%-37.0%HK$1.3bn/aPE4.7xn/a3.9%

1672

Ascletis Pharma
HK$1.302.4%-51.1%HK$1.3bHK$2.98PS21.5xE-9.3%n/a

1167

Jacobio Pharmaceuticals Group
HK$1.6915.8%-75.3%HK$1.3bHK$4.28PS19.5xS59.2%n/a

1875

TOT BIOPHARM International
HK$1.7410.8%-17.5%HK$1.3bHK$3.80PS1.6xn/an/a

2496

Wuhan YZY Biopharma
HK$7.450%n/aHK$1.4bn/aPS111.7xn/an/a

1244

3D Medicines
HK$6.5415.8%-90.7%HK$1.5bn/aPS2.2xn/an/a

2552

Hua Medicine (Shanghai)
HK$1.590%-46.1%HK$1.6bHK$3.13PS18.8xE83.3%n/a

2181

Mabpharm
HK$0.40-5.9%-33.3%HK$1.6bn/aPS17.5xn/an/a

6978

Immunotech Biopharm
HK$3.294.8%-13.9%HK$1.7bn/aPB9xn/an/a

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.18-0.8%-9.9%HK$1.8bn/aPE5xn/a6.8%

2256

Abbisko Cayman
HK$3.308.2%15.8%HK$1.9bHK$8.20PS93.6xE-2.3%n/a

3681

SinoMab BioScience
HK$1.88-1.1%1.1%HK$2.1bn/aPS432.5xn/an/a
Page 2 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.